186 related articles for article (PubMed ID: 21229585)
1. Renal fibrosis: insight from proteomics in animal models and human disease.
Klein J; Kavvadas P; Prakoura N; Karagianni F; Schanstra JP; Bascands JL; Charonis A
Proteomics; 2011 Feb; 11(4):805-15. PubMed ID: 21229585
[TBL] [Abstract][Full Text] [Related]
2. Proteomics in chronic kidney disease: The issues clinical nephrologists need an answer for.
Spasovski G; Ortiz A; Vanholder R; El Nahas M
Proteomics Clin Appl; 2011 Jun; 5(5-6):233-40. PubMed ID: 21538916
[TBL] [Abstract][Full Text] [Related]
3. Review: Serum and urine biomarkers of kidney disease: A pathophysiological perspective.
Tesch GH
Nephrology (Carlton); 2010 Sep; 15(6):609-16. PubMed ID: 20883281
[TBL] [Abstract][Full Text] [Related]
4. Urinary proteomics and drug discovery in chronic kidney disease: a new perspective.
Prunotto M; Ghiggeri GM; Candiano G; Lescuyer P; Hochstrasser D; Moll S
J Proteome Res; 2011 Jan; 10(1):126-32. PubMed ID: 20718506
[TBL] [Abstract][Full Text] [Related]
5. Is the time ripe for kidney tissue proteomics?
Charonis A; Luider T; Baumann M; Schanstra JP
Proteomics Clin Appl; 2011 Jun; 5(5-6):215-21. PubMed ID: 21538914
[TBL] [Abstract][Full Text] [Related]
6. Bone health in chronic kidney disease-mineral and bone disease.
Gal-Moscovici A; Sprague SM
Adv Chronic Kidney Dis; 2007 Jan; 14(1):27-36. PubMed ID: 17200041
[TBL] [Abstract][Full Text] [Related]
7. The kidney as a target organ in pharmaceutical research.
Prunotto M; Gabbiani G; Pomposiello S; Ghiggeri G; Moll S
Drug Discov Today; 2011 Mar; 16(5-6):244-59. PubMed ID: 21129499
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of renal diseases: unraveling the pathophysiology and biomarker discovery.
Thongboonkerd V
Expert Rev Proteomics; 2005 Jun; 2(3):349-66. PubMed ID: 16000082
[TBL] [Abstract][Full Text] [Related]
9. Urinary proteomics: a tool to discover biomarkers of kidney diseases.
Dihazi H; Müller GA
Expert Rev Proteomics; 2007 Feb; 4(1):39-50. PubMed ID: 17288514
[TBL] [Abstract][Full Text] [Related]
10. Experimental diffuse interstitial renal fibrosis. A biochemical approach.
González-Avila G; Vadillo-Ortega F; Pérez-Tamayo R
Lab Invest; 1988 Aug; 59(2):245-52. PubMed ID: 3404976
[TBL] [Abstract][Full Text] [Related]
11. Obstructive nephropathy and renal fibrosis.
Klahr S; Morrissey J
Am J Physiol Renal Physiol; 2002 Nov; 283(5):F861-75. PubMed ID: 12372761
[TBL] [Abstract][Full Text] [Related]
12. Proteomic approaches in the search for biomarkers of liver fibrosis.
Cowan ML; Rahman TM; Krishna S
Trends Mol Med; 2010 Apr; 16(4):171-83. PubMed ID: 20304704
[TBL] [Abstract][Full Text] [Related]
13. Challenges of genomics and proteomics in nephrology.
Stojnev S; Pejcic M; Dolicanin Z; Velickovic LJ; Dimov I; Stefanovic V
Ren Fail; 2009; 31(8):765-72. PubMed ID: 19814648
[TBL] [Abstract][Full Text] [Related]
14. Review: Endothelial-myofibroblast transition, a new player in diabetic renal fibrosis.
Li J; Bertram JF
Nephrology (Carlton); 2010 Aug; 15(5):507-12. PubMed ID: 20649869
[TBL] [Abstract][Full Text] [Related]
15. [Proteomics and the kidney: an innovative approach to the study of renal disease].
Netti GS; Rocchetti MT; Papale M; Centra M; Centonze D; Di Paolo S; Ranieri E; Gesualdo L
G Ital Nefrol; 2008; 25(2):169-82. PubMed ID: 18350497
[TBL] [Abstract][Full Text] [Related]
16. Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease.
Vaziri ND
J Ren Nutr; 2010 Sep; 20(5 Suppl):S35-43. PubMed ID: 20797569
[TBL] [Abstract][Full Text] [Related]
17. [Reversal of renal fibrosis: lessons from experimental models].
Dussaule JC; Chatziantoniou C
Bull Acad Natl Med; 2008 May; 192(5):987-1000; discussion 1000-1. PubMed ID: 19238788
[TBL] [Abstract][Full Text] [Related]
18. Complement C5 mediates experimental tubulointerstitial fibrosis.
Boor P; Konieczny A; Villa L; Schult AL; Bücher E; Rong S; Kunter U; van Roeyen CR; Polakowski T; Hawlisch H; Hillebrandt S; Lammert F; Eitner F; Floege J; Ostendorf T
J Am Soc Nephrol; 2007 May; 18(5):1508-15. PubMed ID: 17389734
[TBL] [Abstract][Full Text] [Related]
19. Renal inflammation is modulated by potassium in chronic kidney disease: possible role of Smad7.
Wang W; Soltero L; Zhang P; Huang XR; Lan HY; Adrogue HJ
Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1123-30. PubMed ID: 17634402
[TBL] [Abstract][Full Text] [Related]
20. Replicative senescence in kidney aging, renal disease, and renal transplantation.
Naesens M
Discov Med; 2011 Jan; 11(56):65-75. PubMed ID: 21276412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
